Enanta Pharma Stock Price (NASDAQ:ENTA)

Add to My Stocks
$92.41 $5.27 (5.4%) ENTA stock closing price Sep 21, 2018 (Closing)
Prev Close* : $97.68
Market Cap:
$1.89B
Day Low: $91.58
52 Week Low: $42.49
Open: $97.84
Volume: -
Day High: $98.08
52 Week High: $127.77
Dividend:
0.00

Latest Stock Market News

Latest Articles

Enanta Pharma News - From Partners

ENTA Stockcharts

View ENTA PE ratio, PS ratio stocks charts and compare with peers.
ENTA Chart
Note: Compare Enanta Pharma stock price history with the index and industry peers.

Enanta Pharma Valuation

PE ratio
(price earnings ratio)
22.93
PS ratio (
price to sales ratio
)
8.28
PB ratio (
price to book ratio
)
5.66

Enanta Pharma Returns

ROE
(return on equity)
26%

Enanta Pharma Financial Ratios

Asset Turnover
0.62
Receivables Turnover
7.56
Debt to Equity
0
Dividend Yield
0%

ENTA Industry Peers

Company Price Change (%)
Ignyta (RXDX)26.950 (0%)
Zogenix (ZGNX)49.150.15 (0.3%)
Intercept Pharma (ICPT)114.174.68 (3.94%)
Regulus Therapeutics (RGLS)0.210.02 (10.53%)
Achillion Pharma (ACHN)3.510.03 (0.85%)
Sciclone Pharma (SCLN)11.150 (0%)
Tobira Therapeutics Inc (TBRA)42.090 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
SIGA Technologies (SIGA)7.230.48 (7.11%)
AcelRx Pharma (ACRX)3.950.25 (6.76%)
ChemoCentryx (CCXI)12.910.54 (4.37%)
Infinity Pharma (INFI)2.40.09 (3.9%)
Redhill Biopharma (RDHL)8.040.14 (1.77%)
Adamis Pharma (ADMP)3.10.05 (1.64%)
BioSpecifics Technologies (BSTC)58.520.78 (1.35%)
Top gainers from Medical-Drugs industry
* As of Sep 21, 2018
CompanyPriceChange (%)
Lannett Co (LCI)50.5 (9.09%)
Neptune Tech. & Bio. (NEPT)4.340.38 (8.05%)
Tetraphase Pharmaceuticals (TTPH)2.920.24 (7.59%)
CORREVIO PHARMA (CORV)4.020.27 (6.29%)
Arrowhead Pharma (ARWR)17.771.11 (5.88%)
Galectin Therapeutics (GALT)6.530.4 (5.77%)
Esperion Therapeutics (ESPR)43.162.59 (5.66%)
Top losers from Medical-Drugs industry
* As of Sep 21, 2018

Enanta Pharmaceuticals Inc Stock News - Partner Headlines

Enanta Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues102.81M88.26M160.88M47.74M32.05M
Net Income17.71M21.66M78.99M34.43M9.62M
Total Operating Expense78.19M57.42M36.72M28.75M23.02M
View Enanta Pharma income statement
balance sheet20172016201520142013
Total Assets326.63M281.27M246.01M155.41M116.97M
Total Liabilities24.96M11.34M9.85M6.76M6.5M
Shareholders Equity301.67M269.93M236.15M148.65M110.46M
View Enanta Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities21.97M6.17M-16.83M-2.25M-
Net Cash from (used by) Operating Activities52.65M35.8M76.67M20.17M10.65M
Increase (Decrease) in Prop Plant And Equipment-2.5M-4.73M-2.32M-1.02M-0.6M
View Enanta Pharma cash flow statement

Enanta Pharma Stock Message Board

Enanta Pharma stock price ended the last trading day at $92.41. The total market value as denoted by $1.89B for Enanta Pharma, is the market value of the company's outstanding shares. Enanta Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The terms stocks and shares mean the same thing. For Ex: Enanta Pharma stock price and Enanta Pharma share price mean the same thing. The volume of shares traded stood at 1,362,669 on the last trading day, as is evident from Enanta Pharma stock chart, and ENTA stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Enanta Pharma dividend per share was 0.00 during the last quarter. Enanta Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.